Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 4,012	$ 10,158
Receivables	14,635	2,849
Total current assets	18,647	13,007
Software	72,288	45,229
Investment in equity method investee	452,064	452,336
Total assets	542,999	510,572
Current liabilities
Accounts payable and accrued liabilities	337,814	480,719
Due to related parties	11,750	11,750
Convertible notes payable, net of discount	53,215	172,230
Derivative liability	72,415	319,041
Total current liabilities	475,194	983,740
Total liabilities	475,194	983,740
Stockholders’ equity (deficit)
Preferred stock, value	400	400
Common stock; $0.0001 par value; 250,000,000 shares authorized; 3,975,519 and 2,435,179 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively.	399	244
Additional paid-in capital	15,173,070	14,676,221
Accumulated deficit	(15,106,271)	(15,150,240)
Total stockholders’ equity (deficit)	67,805	(473,168)
Total liabilities and stockholders’ equity (deficit)	542,999	510,572
Series B Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value	7	7
Series C Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value	$ 200	$ 200